These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25761648)
1. Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy. Mu Q; Jeon M; Hsiao MH; Patton VK; Wang K; Press OW; Zhang M Adv Healthc Mater; 2015 Jun; 4(8):1236-45. PubMed ID: 25761648 [TBL] [Abstract][Full Text] [Related]
2. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model. Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912 [TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related]
5. Magnetic targeting of paclitaxel-loaded poly(lactic- Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603 [TBL] [Abstract][Full Text] [Related]
6. Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery. Hsiao MH; Mu Q; Stephen ZR; Fang C; Zhang M ACS Macro Lett; 2015 Apr; 4(4):403-407. PubMed ID: 26900510 [TBL] [Abstract][Full Text] [Related]
7. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118 [TBL] [Abstract][Full Text] [Related]
9. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma. Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068 [TBL] [Abstract][Full Text] [Related]
10. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
11. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625 [TBL] [Abstract][Full Text] [Related]
12. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
13. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707 [TBL] [Abstract][Full Text] [Related]
14. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo. Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275 [TBL] [Abstract][Full Text] [Related]
15. Temozolomide nanoparticles for targeted glioblastoma therapy. Fang C; Wang K; Stephen ZR; Mu Q; Kievit FM; Chiu DT; Press OW; Zhang M ACS Appl Mater Interfaces; 2015 Apr; 7(12):6674-82. PubMed ID: 25751368 [TBL] [Abstract][Full Text] [Related]
16. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells. Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155 [TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259 [TBL] [Abstract][Full Text] [Related]
18. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628 [TBL] [Abstract][Full Text] [Related]
19. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
20. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]